◼ Archived
Health
Scientists Analyzed Thousands of Psychedelic Trips. They Found Something Disturbing
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Psychedelics
9 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
A fast-acting nasal spray offers hope for hard-to-treat depression: study
A new study reveals a psychedelic nasal spray can improve severe depression symptoms within 48 hours.
◼ Archived
Health
Single dose of fast-acting psychedelic nasal spray shows promise for stubborn depression
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Nose Spray Made From Toad Venom Compound Quickly Eases Depression For Weeks in Clinical Trial
A psychedelic nasal spray derived from a toad venom compound shows rapid promise for easing stubborn depression in clinical trials.
◼ Archived
Science
One with the world? A new look at brains transformed by psychedelics.
Recent studies in PsyPost, BBC Wildlife Magazine, and Nature examine how psychedelics like LSD and psilocybin transform the brain.
◼ Archived
Business
Psychedelics Stock, Up 190% This Year, Flies High Again
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Experts urge FDA to set clear safety and access standards for psychedelic drugs
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
This Billionaire Made $360 Million Selling His Psychedelic Company To Eli Lilly
Eli Lilly has expanded its neuropsychiatric portfolio through a multi-billion dollar acquisition of Atai, a psychedelic research company.
◼ Archived
Business
🔮 fades
Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports
Eli Lilly is entering the psychedelic drug market with a deal to acquire AtaiBeckley for up to $3.8 billion to treat resistant depression.